During the past decade, UPMC Cancer Center at UPMC Passavant conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 13 clinical trials were completed, i.e. on average, 185.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Passavant" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "University of Pittsburgh" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Ahmad Tarhini" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Passavant" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center at UPMC Passavant" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Esophageal Cancer" (2 trials), "Metastatic Cancer" (2 trials) and "Adenoid Cystic Carcinoma" (1 trials). Many other conditions were trialed in "UPMC Cancer Center at UPMC Passavant" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center at UPMC Passavant" are "Drug" (17 trials), "Radiation" (8 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (3 trials), "LHRH agonist" (2 trials), "cisplatin" (2 trials), "AA" (1 trials) and "Calcium" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center at UPMC Passavant" are 12 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center at UPMC Passavant". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UPMC Cancer Center at UPMC Passavant, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center at UPMC Passavant, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".